|
US7405210B2
(en)
|
2003-05-21 |
2008-07-29 |
Osi Pharmaceuticals, Inc. |
Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
|
|
JP2006528702A
(ja)
*
|
2003-05-21 |
2006-12-21 |
プロシディオン・リミテッド |
グリコーゲンホスホリラーゼのピロロピリジン−２−カルボン酸アミドインヒビター
|
|
GB0314967D0
(en)
|
2003-06-26 |
2003-07-30 |
Hoffmann La Roche |
Piperazine derivatives
|
|
TW200528102A
(en)
*
|
2003-10-24 |
2005-09-01 |
Solvay Pharm Gmbh |
Novel medical combination treatment of obesity involving 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
|
|
EP1680116A1
(en)
*
|
2003-10-24 |
2006-07-19 |
Solvay Pharmaceuticals GmbH |
Combination treatment of obesity involving selective cb1-antagonists and lipase inhibitors
|
|
EP1792629A4
(en)
|
2004-08-25 |
2010-08-25 |
Takeda Pharmaceutical |
MEANS FOR THE PREVENTION / TREATMENT OF STRESS-RELATED HARNINE INCONTINENCE AND PRECAUTIONARY METHOD FOR THIS
|
|
MX2007004889A
(es)
|
2004-10-25 |
2007-09-11 |
Solvay Pharm Gmbh |
Composiciones farmaceuticas que comprenden antagonistas del receptor cannabinoide cb1 y activadores de canales de potasio para el tratamiento de la diabetes mellitus tipo i, la obesidad y trastornos relacionados.
|
|
AU2006243243B2
(en)
*
|
2005-05-03 |
2009-05-14 |
F. Hoffmann-La Roche Ag |
Tetracyclic azapyrazinoindolines as 5-HT2 ligands
|
|
WO2006125179A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Xenon Pharmaceuticals Inc. |
Tricyclic compounds and their uses as therapeutic agents
|
|
RU2417226C2
(ru)
*
|
2005-11-18 |
2011-04-27 |
Ф.Хоффманн-Ля Рош Аг |
Производные азаиндол-2-карбоксамида
|
|
WO2007065820A1
(en)
*
|
2005-12-09 |
2007-06-14 |
F. Hoffmann-La Roche Ag |
Tricyclic amide derivatives useful for treating obesity
|
|
JP2009519293A
(ja)
|
2005-12-16 |
2009-05-14 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｈ３レセプター調節剤としてのピロロ［２，３−ｂ］ピリジン誘導体
|
|
EP2727585A1
(en)
|
2006-05-16 |
2014-05-07 |
Takeda Pharmaceutical Company Limited |
In-vivo screening method
|
|
BRPI0715160A2
(pt)
|
2006-08-08 |
2013-06-11 |
Sanofi Aventis |
imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso
|
|
EP2216023A4
(en)
|
2007-11-15 |
2013-03-13 |
Takeda Pharmaceutical |
CONDENSED PYRIDINE DERIVATIVE AND ITS USE
|
|
WO2010003624A2
(en)
|
2008-07-09 |
2010-01-14 |
Sanofi-Aventis |
Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
DK2470552T3
(en)
|
2009-08-26 |
2014-02-17 |
Sanofi Sa |
NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE
|
|
JPWO2011071136A1
(ja)
|
2009-12-11 |
2013-04-22 |
アステラス製薬株式会社 |
線維筋痛症治療剤
|
|
FR2960876B1
(fr)
*
|
2010-06-03 |
2012-07-27 |
Sanofi Aventis |
Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8809325B2
(en)
|
2011-03-08 |
2014-08-19 |
Sanofi |
Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
|
|
WO2012120050A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2683703B1
(de)
|
2011-03-08 |
2015-05-27 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120058A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120054A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8710050B2
(en)
|
2011-03-08 |
2014-04-29 |
Sanofi |
Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2013163239A1
(en)
*
|
2012-04-26 |
2013-10-31 |
Francis Xavier Tavares |
Synthesis of lactams
|
|
KR101716062B1
(ko)
*
|
2012-08-06 |
2017-03-13 |
에프. 호프만-라 로슈 아게 |
피페라지노[1,2-a]인돌-1-온 및 [1,4]다이아제피노[1,2-a]인돌-1-온
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
EP3500570B1
(en)
*
|
2016-08-19 |
2022-10-05 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
JPWO2019131902A1
(ja)
|
2017-12-27 |
2020-12-10 |
武田薬品工業株式会社 |
腹圧性尿失禁および便失禁の治療薬
|